Rhabdomyosarcoma of Mediastinum
Showing 1 - 25 of 156
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Boston (Stereotactic Body Radiotherapy (SBRT))
Terminated
- Ewing Sarcoma
- +10 more
- Stereotactic Body Radiotherapy (SBRT)
-
Boston, Massachusetts
- +2 more
Apr 5, 2021
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
Not yet recruiting
- Rhabdomyosarcoma
-
San Francisco, CaliforniaPower Life Sciences
Sep 1, 2023
Saliva or Buccal Mucosa Samples From Embryonal or Alveolar
Recruiting
- Alveolar Rhabdomyosarcoma
- Embryonal Rhabdomyosarcoma
- Biospecimen Collection
- +2 more
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Aug 8, 2022
FFPE Samples From Younger Patients With Rhabdomyosarcoma
Completed
- Alveolar Childhood Rhabdomyosarcoma
- +2 more
-
Jinan, Shandong, ChinaJinan central hospital affiliated to Shandong First Medical Univ
Sep 10, 2023
Thyroid Disease Trial in Syracuse (SPECT)
Enrolling by invitation
- Thyroid Disease
- SPECT
-
Syracuse, New YorkSUNY Upstate Medical University
Aug 31, 2023
Embryonal Rhabdomyosarcoma, Fusion-Negative Alveolar Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma Trial in United
Recruiting
- Embryonal Rhabdomyosarcoma
- +2 more
- Cyclophosphamide
- +3 more
-
Birmingham, Alabama
- +47 more
Aug 17, 2022
Relapsed/Refractory Rhabdomyosarcoma, Non-rhabdomyosarcoma Soft Tissue Sarcoma, Ewing Sarcoma Trial in United States (Eribulin
Completed
- Relapsed/Refractory Rhabdomyosarcoma
- +2 more
- Eribulin mesylate
-
Birmingham, Alabama
- +40 more
Mar 18, 2022
Rhabdomyosarcoma, Child Trial (Realgar-Indigo Naturalis Formulation, Radiotherapy)
Not yet recruiting
- Rhabdomyosarcoma, Child
- Realgar-Indigo Naturalis Formulation
- Radiotherapy
- (no location specified)
Jan 31, 2023
Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin
Completed
- Refractory or Recurrent Solid Tumors
- +3 more
- Eribulin mesilate
- Irinotecan hydrochloride
-
Marseille, Bouches-du-Rhône, France
- +38 more
Jun 20, 2022
Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)
Not yet recruiting
- Rhabdomyosarcoma, Child
- Doxorubicin Hydrochloride Liposome+Irinotecan
- Temozolomide+Irinotecan+Vincristine
- (no location specified)
Jul 13, 2022
Mediastinum Disease Trial in Changsha (AI system)
Recruiting
- Mediastinum Disease
- AI system
-
Changsha, Hunan, ChinaThe Third Xiangya Hospital of Central South University
Mar 29, 2023
Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma Trial in Worldwide (drug,
Suspended
- Alveolar Rhabdomyosarcoma
- +5 more
- Cyclophosphamide
- +8 more
-
Birmingham, Alabama
- +386 more
Aug 18, 2022
Cysts Trial in Maastricht
Recruiting
- Cysts
-
Maastricht, Limburg, NetherlandsMaastricht UMC
Apr 20, 2023
Refractory and/or Relapsed Metastatic Solid Tumors Trial in United States (Cyclophosphamide, Fludarabine, low dose total body
Recruiting
- Refractory and/or Relapsed Metastatic Solid Tumors
- Cyclophosphamide
- +4 more
-
Saint Petersburg, Florida
- +4 more
Oct 29, 2021
Ventricular Arrhythmia, Ventricular Tachycardia, Ventricular Fibrillation Trial in Asunción (AtaCor EV-ICD Lead)
Completed
- Ventricular Arrhythmia
- +2 more
- AtaCor EV-ICD Lead
-
Asunción, ParaguaySanatorio Italiano
Jul 5, 2022
Thoracic Scanographic Characteristics of Hematologic Malignancy
Recruiting
- Mediastinal Diseases
- analysis of thoracic scans
-
Toulouse, FranceMuriel Picard
Jan 12, 2023
Rhabdomyosarcoma Trial in Los Angeles (Vinorelbine, Mocetinostat)
Recruiting
- Rhabdomyosarcoma
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
May 13, 2022
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)
Recruiting
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
- GEM/DOX + TGFBi expanded NK cells
-
Tampa, Florida
- +1 more
Jan 3, 2023
Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma Trial in Worldwide
Completed
- Adult Rhabdomyosarcoma
- +3 more
- conventional surgery
- +4 more
-
Birmingham, Alabama
- +162 more
Nov 17, 2021
Recurrent and Refractory Solid Tumors Trial in Canada, United States (Lenvatinib, Everolimus)
Completed
- Recurrent and Refractory Solid Tumors
-
Birmingham, Alabama
- +49 more
Jan 27, 2023
Soft Tissue Sarcoma Trial in Worldwide (trofosfamide, idarubicin, etoposide)
Active, not recruiting
- Soft Tissue Sarcoma
- trofosfamide, idarubicin, etoposide
-
Graz, Austria
- +73 more
Nov 12, 2021